Prognostic Value of Late Gadolinium Enhancement in Postoperative Morbidity following Mitral Valve Surgery in

Teuku Muhammad Haykal Putra1, Renan Sukmawan1, Elen Elen1

  • 1Department of Cardiology and Vascular Medicine, Division of Nuclear Cardiology and Cardiovascular Imaging, Faculty of Medicine, Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.

Insights

Myocardial fibrosis, a scarring of heart muscle, is common in rheumatic mitral stenosis patients undergoing valve surgery. Higher fibrosis levels correlate with increased postoperative complications, highlighting its prognostic significance.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Rheumatic mitral stenosis (MS) involves chronic inflammation leading to myocardial fibrosis.
  • Myocardial fibrosis is a known predictor of adverse outcomes in various cardiac conditions.
  • The prognostic impact of myocardial fibrosis in rheumatic MS patients undergoing mitral valve surgery remains underexplored.

Purpose of the Study:

  • To investigate the prognostic value of myocardial fibrosis in predicting postoperative morbidity after mitral valve surgery in patients with rheumatic MS.

Main Methods:

  • Prospective observational study of 47 consecutive rheumatic MS patients.
  • Preoperative cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE) assessed left ventricular myocardial fibrosis.
  • Patients were monitored for postoperative morbidities including stroke, renal failure, and prolonged mechanical ventilation.

Main Results:

  • Preoperative myocardial fibrosis was detected in 91.5% of patients, with a median fibrosis volume of 2.8%.
  • Postoperative morbidities occurred in 23.4% of patients.
  • A significant association was found between higher myocardial fibrosis volume and increased postoperative morbidity (5.97% vs. 3.12%, p=0.04).

Conclusions:

  • Extensive myocardial fibrosis is linked to a higher risk of postoperative morbidity in rheumatic MS patients undergoing mitral valve surgery.
  • Myocardial fibrosis assessment may aid in risk stratification for these patients.
  • Further research is warranted to elucidate the mechanisms linking fibrosis to adverse outcomes.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
175
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
271
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
203
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
347
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
328
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
222